302 related articles for article (PubMed ID: 35410432)
21. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic cancer cell-derived microRNA-155-5p-containing extracellular vesicles promote immune evasion by triggering EHF-dependent activation of Akt/NF-κB signaling pathway.
Wang S; Gao Y
Int Immunopharmacol; 2021 Nov; 100():107990. PubMed ID: 34482266
[TBL] [Abstract][Full Text] [Related]
23. Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
Sun X; Xin S; Zhang Y; Jin L; Liu X; Zhang J; Mei W; Zhang B; Ma W; Ye L
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35904175
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
25. LncRNA AL139294.1 can be transported by extracellular vesicles to promote the oncogenic behaviour of recipient cells through activation of the Wnt and NF-κB2 pathways in non-small-cell lung cancer.
Ma X; Chen Z; Chen W; Chen Z; Shang Y; Zhao Y; Li L; Zhou C; He J; Meng X
J Exp Clin Cancer Res; 2024 Jan; 43(1):20. PubMed ID: 38229152
[TBL] [Abstract][Full Text] [Related]
26. YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.
Cui Q; Wang C; Liu S; Du R; Tian S; Chen R; Geng H; Subramanian S; Niu Y; Wang Y; Yue D
Cell Cycle; 2021 Nov; 20(22):2413-2427. PubMed ID: 34709966
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA circATP9A promotes non-small cell lung cancer progression by interacting with HuR and by promoting extracellular vesicles-mediated macrophage M2 polarization.
Yao Y; Chen C; Wang J; Xuan H; Chen X; Li Z; Yang F; Wang B; Lin S; Li S; Tang D; Gong L; Gao W
J Exp Clin Cancer Res; 2023 Dec; 42(1):330. PubMed ID: 38049814
[TBL] [Abstract][Full Text] [Related]
28. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro.
Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165
[TBL] [Abstract][Full Text] [Related]
29. Human umbilical vein endothelial cells-derived microRNA-203-containing extracellular vesicles alleviate non-small-cell lung cancer progression through modulating the DTL/p21 axis.
Ma T; Hu Y; Guo Y; Zhang Q
Cancer Gene Ther; 2022 Jan; 29(1):87-100. PubMed ID: 33558703
[TBL] [Abstract][Full Text] [Related]
30. Reduction of miR-744 delivered by NSCLC cell-derived extracellular vesicles upregulates SUV39H1 to promote NSCLC progression via activation of the Smad9/BMP9 axis.
Gao L; Tian Q; Wu T; Shi S; Yin X; Liu L; Zheng L; Wang P; Tian Y; Xu S
J Transl Med; 2021 Jan; 19(1):37. PubMed ID: 33472665
[TBL] [Abstract][Full Text] [Related]
31. CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation.
Shi H; Niimi A; Takeuchi T; Shiogama K; Mizutani Y; Kajino T; Inada K; Hase T; Hatta T; Shibata H; Fukui T; Chen-Yoshikawa TF; Nagano K; Murate T; Kawamoto Y; Tomida S; Takahashi T; Suzuki M
Cancer Sci; 2021 Jul; 112(7):2770-2780. PubMed ID: 33934437
[TBL] [Abstract][Full Text] [Related]
32. [Not Available].
Liu L; Chen Y; Zhang T; Cui G; Wang W; Zhang G; Li J; Zhang Y; Wang Y; Zou Y; Ren Z; Xue W; Sun R
Adv Sci (Weinh); 2024 May; 11(20):e2302379. PubMed ID: 38566431
[TBL] [Abstract][Full Text] [Related]
33. LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1.
Deng X; Xiong W; Jiang X; Zhang S; Li Z; Zhou Y; Xiang B; Zhou M; Li X; Li G; Zeng Z; Gong Z
Cell Death Dis; 2020 Nov; 11(11):945. PubMed ID: 33144579
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4.
Zhang L; Hu J; Li J; Yang Q; Hao M; Bu L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1595-1602. PubMed ID: 31010333
[TBL] [Abstract][Full Text] [Related]
35. PIN1P1 is activated by CREB1 and promotes gastric cancer progression via interacting with YBX1 and upregulating PIN1.
Wang YW; Zhu WJ; Ma RR; Tian YR; Chen X; Gao P
J Cell Mol Med; 2024 Jan; 28(1):e18022. PubMed ID: 37929660
[TBL] [Abstract][Full Text] [Related]
36. Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis.
Li J; Zhang B; Feng Z; An D; Zhou Z; Wan C; Hu Y; Sun Y; Wang Y; Liu X; Wei W; Yang X; Meng J; Che M; Sheng Y; Wu B; Wen L; Huang F; Li Y; Yang K
J Exp Clin Cancer Res; 2024 Jan; 43(1):28. PubMed ID: 38254206
[TBL] [Abstract][Full Text] [Related]
37. LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma.
Wang Y; Feng YC; Gan Y; Teng L; Wang L; La T; Wang P; Gu Y; Yan L; Li N; Zhang L; Wang L; Thorne RF; Zhang XD; Cao H; Shao FM
J Exp Clin Cancer Res; 2022 Aug; 41(1):260. PubMed ID: 36028903
[TBL] [Abstract][Full Text] [Related]
38. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
39. hnRNPA2B1-Mediated Extracellular Vesicles Sorting of miR-122-5p Potentially Promotes Lung Cancer Progression.
Li C; Qin F; Wang W; Ni Y; Gao M; Guo M; Sun G
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884671
[TBL] [Abstract][Full Text] [Related]
40. Extracellular Vesicles Derived circSH3PXD2A Inhibits Chemoresistance of Small Cell Lung Cancer by miR-375-3p/YAP1.
Chao F; Zhang Y; Lv L; Wei Y; Dou X; Chang N; Yi Q; Li M
Int J Nanomedicine; 2023; 18():2989-3006. PubMed ID: 37304971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
